Low Resolution Limits and Inaccurate Algorithms Decrease Significantly the Value of Late Loss in Current Drug-Eluting Stent Trials
Quantitative coronary and vascular angiography (QCA resp., QVA) remains the current gold standard for evaluation of restenosis. Late loss as one of the most commonly accepted parameters to highlight efficacy of the various devices has shown high correlation to clinical parameters but, surprisingly,...
Saved in:
Main Authors: | Johannes B. Dahm, Frank van Buuren |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Vascular Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/417250 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient Safety Events Related to the Placement of Drug-Eluting Stents
by: Patient Safety Authority
Published: (2023-12-01) -
Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01) -
Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
by: Robert J. Gil, et al.
Published: (2020-01-01) -
Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅰ: Drug transport
by: Tuoi Vo, et al.
Published: (2017-03-01) -
Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)